PetMed Express CFO Departs, Interim Appointed
Ticker: PETS · Form: 8-K · Filed: 2024-08-05T00:00:00.000Z
Sentiment: neutral
Topics: executive-departure, cfo-appointment, compensation
Related Tickers: PETS
TL;DR
CFO out at PETS, interim steps in. Keep an eye on the next steps.
AI Summary
PetMed Express, Inc. announced on August 2, 2024, the departure of its Chief Financial Officer, Jeffrey W. Atwood, effective August 5, 2024. The company also announced the appointment of Michael J. Slifka as interim CFO. Additionally, the company reported on executive compensation arrangements.
Why It Matters
A CFO departure can signal financial strategy shifts or internal challenges, while an interim appointment suggests a search for a permanent replacement is underway.
Risk Assessment
Risk Level: medium — A sudden CFO departure can indicate underlying issues or uncertainty within the company's financial management.
Key Players & Entities
- PetMed Express, Inc. (company) — Registrant
- Jeffrey W. Atwood (person) — Departing Chief Financial Officer
- August 5, 2024 (date) — Effective date of CFO departure
- Michael J. Slifka (person) — Interim Chief Financial Officer
- August 2, 2024 (date) — Date of report
FAQ
Who has been appointed as the interim Chief Financial Officer?
Michael J. Slifka has been appointed as the interim Chief Financial Officer.
When is Jeffrey W. Atwood's departure as CFO effective?
Jeffrey W. Atwood's departure as CFO is effective August 5, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at 420 South Congress Avenue, Delray Beach, Florida 33445.
What is the filing date of this Current Report?
The filing date of this Current Report is August 5, 2024.
What are the main items reported in this 8-K filing?
This 8-K filing reports on the departure of a director or certain officer, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD Disclosure, and Financial Statements and Exhibits.
From the Filing
0001040130-24-000062.txt : 20240805 0001040130-24-000062.hdr.sgml : 20240805 20240805162752 ACCESSION NUMBER: 0001040130-24-000062 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240802 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240805 DATE AS OF CHANGE: 20240805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28827 FILM NUMBER: 241175190 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20240802.htm 8-K pets-20240802 0001040130 FALSE 0001040130 2024-08-02 2024-08-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  August 2, 2024 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Officer On August 2, 2024, the Board of Directors of PetMed Express, Inc. (“Company”) appointed Doug Krulik to serve as the Company’s Chief Accounting Officer to assume the duties of principal accounting officer and interim-principal financial officer effective August 19, 2024 (“Effective Date”). Mr. Krulik, age 55, brings over 20 years of accounting and finance experience to the Company. Most recently, he served as Vice President Finance and Controller at Etherio Holdings, a private events and marketing company